Approval · Notice of Compliance 22018 · 2019
NITRO-DUR 0.2: Notice of Compliance 22018
Issued March 29, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22018
- Date
- March 29, 2019
- Company
- Uspharma LtdMiami, Florida, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the product monograph, inner and outer labels and package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NITRO-DUR 0.2 | Not yet assigned | — |
| NITRO-DUR 0.4 | Not yet assigned | — |
| NITRO-DUR 0.6 | Not yet assigned | — |
| NITRO-DUR 0.8 | Not yet assigned | — |
Medicinal ingredients
- NITROGLYCERIN 0.2 MG per HR
- NITROGLYCERIN 0.4 MG per HR
- NITROGLYCERIN 0.6 MG per HR
- NITROGLYCERIN 0.8 MG per HR